ScripPublic biopharma companies usually spend the week before the J.P. Morgan Healthcare Conference announcing new financings, partnerships and sometimes data so that they have compelling milestones to dis
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With UK’s Alchemab On A
Pink SheetPharma supply chains still may feel some long-lasting impacts from the proposed BIOSECURE Act, even though the bill appears unlikely to be enacted this year or perhaps ever, although it probably is to
ScripThe BIOSECURE Act, when enacted, could leave some US pharma firms with pretty big shoes to fill given that it will strip the supply pool of WuXi AppTec Inc. , WuXi Biologics , Complete Genomics Inc